Amicus Therapeutics

-$0.36 (-3.79%) As of 8:55 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.

About FOLD

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases.

CEO
John Francis Crowley
Employees
483
Headquarters
Philadelphia, Pennsylvania
Founded
2002

FOLD Key Statistics

Market cap
2.56B
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.93M
High today
$9.92
Low today
$9.10
Open price
$9.72
Volume
1.78M
52 Week high
$21.07
52 Week low
$8.41

FOLD News

ReutersJan 21

FOLD.OQ - Amicus Therapeutics, Inc. Profile

About Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. is a global biotechnology company that is focused on discovering, developing, and delivering medicine

FOLD Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure